Dr. Jeffry Gerson: Improving AMD Outcomes with the AdaptDx

Jeffry Gerson, OD, FAAO, discusses the AdaptDx by MacuLogix and how he is using it in his practice to uncover previously undetected cases of age-related macular degeneration. To learn more, visit www.maculogix.com.
Dr. Gerson is one of the Medical Directors for the Macular Degeneration Association.

Apr 16, 2024

Treatment challenges in patients with nAMD

Apr 16, 2024

Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410

Apr 15, 2024

New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain

Newsletter Sign-up

Name**
Email**
CAPTCHA
Name
This field is for validation purposes and should be left unchanged.

5969 Cattleridge Boulevard, Suite 100
Sarasota, Florida 34232

(855) 962-2852 info@macularhope.org

https://www.facebook.com/macularhope/ https://twitter.com/macularhope?lang=en

The Macular Degeneration Association, Inc. is a registered 501(c)(3) non-profit corporation. A copy of the official registration and financial information may be obtained from the division of consumer services by calling toll-free within the state (1-800-help-fla) or on the consumer services website www.800helpfla.com. Registration does not imply endorsement, approval, or recommendation by the state.

| Privacy & Terms